Skip to main content
  • Sign in
    Welcome !
    My account
    Logout
  1. Life Sciences
  2. Biological Products, (No Diagnostic Substances)
  3. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) Stock Forecast

Stock Price Forecast

Aug. 15, 2025

Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict

Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Kyverna Therapeutics, Inc. chart...

About the Company

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases. The CRISPR gene editing system was originally invented by Jennifer Doudna, one of Intellia's scientific founders, (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has entered into a number of different research and development collaborations with leading and emerging biotechnology companies including Novartis, Regeneron, Avencell, SparingVision, Kyverna, and ONK Therapeutics. Intellia has two in vivo programs in ongoing clinical trials. NTLA-2001 is an investigational CRISPR therapy candidate for the treatment for ATTR amyloidosis currently in Phase 1 studies. NTLA-2002 is an investigational CRISPR therapy candidate for the treatment of hereditary angioedema (HAE) currently in Phase 1 / 2 studies. Intellia's proprietary non-viral gene knock out platform deploys lipid nanoparticles to deliver to the liver a two-part genome editing system: guide RNA specific to the disease-causing gene and messenger RNA that encodes the Cas9 enzyme, which carries out the precision editing. Intellia also has a number of research programs for in vivo and ex vivo therapeutic candidates with potential applications in diseases including cancer, alpha-1 antitrypsin deficiency, and hemophilia. The company is also working on a variety of additional gene editing technologies including base editing and DNA writing.

Sector

Life Sciences

Industry

Biological Products, (No Diagnostic Substances)

Exchange

Nasdaq

$M

Total Revenue

None

Employees

$152M

Market Capitalization

None

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 ... - Nasdaq

7mon ago, source: Nasdaq

RADNOR, PA-- December 27, 2024- The law firm of Kessler Topaz Meltzer& Check, LLP informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. on ...

Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

5d ago, source: Yahoo Finance

Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) andBLA submission anticipated in 1H ...

Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds ...

6mon ago, source: Morningstar

Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX ...

Kyverna Therapeutics, Inc. Class Action: The Gross Law Firm Reminds ...

6mon ago, source: Morningstar

Provided by PR NewswireJan 27, 2025 10:45am Kyverna Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead ...

Kyverna Therapeutics Advances CAR T-Cell Therapy Trials

5d ago, source: None

Kyverna Therapeutics, Inc. ( ($KYTX) ) has released its Q2 earnings. Here is a breakdown of the information Kyverna Therapeutics, Inc. presented ...

KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with ...

7mon ago, source: Seeking Alpha

In the IPO, Kyverna offered 14.5 million shares of common stock at a price of $22.00 per share and Kyverna received net proceeds of approximately $296 million.

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws ...

8mon ago, source: Business Insider

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Reach Out To The Schall Law Firm PRESS RELEASE ACCESS Newswire Dec. 11, 2024, 08:45 PM ...

Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit ...

8mon ago, source: KLFY News 10

If you suffered a loss in Kyverna Therapeutics, Inc. during the relevant time frame, you have until February 7, 2025 to request that the Court appoint you as lead plaintiff.

institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX ...

9mon ago, source: Yahoo Finance

A look at the shareholders of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) can tell us which group is most powerful. With 40% stake, institutions possess the maximum shares in the company.

Kyverna Therapeutics Inc | Reuters

1y ago, source: Reuters

Kyverna Therapeutics expects up to $857.3 million valuation in its U.S. initial public offering (IPO), the biotechnology company said on Tuesday as it raised its offering.

Kyverna Therapeutics, Inc.: Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

5d ago, source: FinanzNachrichten.de

Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) andBLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to inclu ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Acumen Pharmaceuticals, Inc. ABOS Predict 86.01 -1.85 0.73
Abpro Holdings, Inc. ABP Predict 0.00 None 0.00
Abpro Holdings, Inc. ABPWW Predict 0.00 None 0.00
Arcellx, Inc. ACLX Predict 3724.66 -74.09 8.93
Alpha Cognition Inc. ACOG Predict 136.20 None 4.27
Adaptimmune Therapeutics PLC ADAP Predict 95.42 -13.20 -11.77
ADMA BIOLOGICS, INC. ADMA Predict 4175.30 19.98 10.48
Adaptive Biotechnologies Corp ADPT Predict 1983.14 -4.61 11.04
Adverum Biotechnologies, Inc. ADVM Predict 57.66 -1.75 2.18
AGENUS INC AGEN Predict 138.92 -0.47 -0.49
AIM ImmunoTech Inc. AIM Predict 2.03 -0.48 -183.28
AIM ImmunoTech Inc. AIMI Predict 2.03 None None
Alector, Inc. ALEC Predict 217.10 -1.19 3.05
Aligos Therapeutics, Inc. ALGS Predict 72.39 -19.24 0.71
Allogene Therapeutics, Inc. ALLO Predict 242.15 -1.39 0.70
Kalaris Therapeutics, Inc. ALVR Predict 49.48 -0.48 0.44
AMGEN INC AMGN Predict 160390.27 24.23 21.59
Apogee Therapeutics, Inc. APGE Predict 2183.72 -20.51 4.25
Aptose Biosciences Inc. APTO Predict 5.90 -0.04 -1.30
Aptose Biosciences Inc. APTOF Predict 3.17 None None
Armata Pharmaceuticals, Inc. ARMP Predict 92.29 -0.99 -1.62
Artiva Biotherapeutics, Inc. ARTV Predict 66.99 None 0.45
Athira Pharma, Inc. ATHA Predict 15.82 -0.21 0.49
Atara Biotherapeutics, Inc. ATRA Predict 142.27 24.55 -1.08
aTYR PHARMA INC ATYR Predict 515.34 -3.56 6.87
Aura Biosciences, Inc. AURA Predict 417.12 -4.92 2.39
Autolus Therapeutics plc AUTL Predict 481.70 None 1.39
ANAVEX LIFE SCIENCES CORP. AVXL Predict 849.42 -17.34 9.34
BioAtla, Inc. BCAB Predict 124.77 -1.05 1.00
BioCardia, Inc. BCDA Predict 11.81 -0.59 -7.77
BRAINSTORM CELL THERAPEUTICS INC. BCLI Predict 6.38 -4.86 -0.89
BIOCRYST PHARMACEUTICALS INC BCRX Predict 1801.64 -12.05 -3.99
Black Diamond Therapeutics, Inc. BDTX Predict 158.63 10.99 1.20
Beam Therapeutics Inc. BEAM Predict 1795.52 -12.55 1.72
BIOGEN INC. BIIB Predict 18125.49 12.80 1.54
Black Hawk Acquisition Corp BKHA Predict 0.00 None 0.00
Black Hawk Acquisition Corp BKHAU Predict 0.00 None 0.00
bluebird bio, Inc. BLUE Predict 48.67 -0.17 -0.84
Cabaletta Bio, Inc. CABA Predict 156.38 -1.57 0.88
Candel Therapeutics, Inc. CADL Predict 337.69 -4.60 4.52
C4 Therapeutics, Inc. CCCC Predict 206.62 -2.63 1.19
Cidara Therapeutics, Inc. CDTX Predict 728.26 -0.96 5.14
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ Predict 8.05 -3.38 1.18
CERO THERAPEUTICS HOLDINGS, INC. CERO Predict 27.42 None -196.22
CERO THERAPEUTICS HOLDINGS, INC. CEROW Predict 1.74 None -0.47
Cullinan Therapeutics, Inc. CGEM Predict 449.26 -4.05 0.81
COMPUGEN LTD CGEN Predict 133.76 None 2.66
CG Oncology, Inc. CGON Predict 1998.80 None 2.98
COGNITION THERAPEUTICS INC CGTX Predict 100.04 -0.47 14.23
Pelthos Therapeutics Inc. CHRO Predict 8.35 None -1.99
Coherus Oncology, Inc. CHRS Predict 122.03 0.68 1.02
Calidi Biotherapeutics, Inc. CLDI Predict 17.94 -0.92 10.17
Compass Therapeutics, Inc. CMPX Predict 410.70 -4.81 4.41
Coeptis Therapeutics Holdings, Inc. COEPW Predict None None None
Caribou Biosciences, Inc. CRBU Predict 184.38 -1.51 1.11
Cardiff Oncology, Inc. CRDF Predict 162.32 -4.00 2.77
CARGO Therapeutics, Inc. CRGX Predict 217.89 None 0.92
CURIS INC CRIS Predict 19.60 -0.30 -2.85
CRISPR Therapeutics AG CRSP Predict 5278.72 -12.09 3.08
CHAMPIONS ONCOLOGY, INC. CSBR Predict 111.31 -17.77 20.35
CEL SCI CORP CVM Predict 46.30 -0.93 6.59
Cyclo Therapeutics, Inc. CYTH Predict 26.18 -0.57 -1.94
Cyclo Therapeutics, Inc. CYTHW Predict 6.65 None -0.49
DBV Technologies S.A. DBVT Predict 1479.05 -3.33 514.81
Ginkgo Bioworks Holdings, Inc. DNA Predict 567.98 -13.93 0.33
Denali Therapeutics Inc. DNLI Predict 2110.86 -8.66 1.88
PRECISION BIOSCIENCES INC DTIL Predict 54.81 -2.17 1.61
DYADIC INTERNATIONAL INC DYAI Predict 28.05 -7.31 11.35
Editas Medicine, Inc. EDIT Predict 231.05 -0.80 3.70
Elevation Oncology, Inc. ELEV Predict 22.21 -0.96 0.48
ELUTIA INC. ELUT Predict 90.43 -1.42 -0.06
enGene Holdings Inc. ENGN Predict 187.94 3.71 0.83
enGene Holdings Inc. ENGNW Predict 37.21 None 0.14
Entera Bio Ltd. ENTX Predict 90.90 8.51 5.27
ENZO BIOCHEM INC ENZ Predict 25.15 -2.98 0.54
ENZO BIOCHEM INC ENZB Predict 36.16 None 0.83
Estrella Immunopharma, Inc. ESLA Predict 33.73 -3.06 -16.85
Estrella Immunopharma, Inc. ESLAW Predict 3.98 None 5.33
EXELIXIS, INC. EXEL Predict 10868.81 18.05 5.34
EXOZYMES INC. EXOZ Predict 81.79 None 11.30
FATE THERAPEUTICS INC FATE Predict 129.11 -1.29 0.49
4D Molecular Therapeutics, Inc. FDMT Predict 405.37 -2.98 0.96
FENNEC PHARMACEUTICALS INC. FENC Predict 231.85 1758.27 -39.67
Finch Therapeutics Group, Inc. FNCH Predict 20.39 -0.05 1.43
FutureTech II Acquisition Corp. FTII Predict -26.18 None -0.72
FutureTech II Acquisition Corp. FTIIU Predict -25.54 None -0.78
FutureTech II Acquisition Corp. FTIIW Predict 0.01 None 0.00
GILEAD SCIENCES, INC. GILD Predict 148791.09 23.58 7.56
Monte Rosa Therapeutics, Inc. GLUE Predict 379.64 15.71 1.42
Genenta Science S.p.A. GNTA Predict 64.11 None 5.13
Green Planet Bio Engineering Co. Ltd. GPLB Predict None None None
HALOZYME THERAPEUTICS, INC. HALO Predict 8439.16 15.14 25.36
HilleVax, Inc. HLVX Predict 104.26 -0.60 0.70
Humacyte, Inc. HUMA Predict 293.92 -3.31 72.54
Humacyte, Inc. HUMAW Predict 162.99 None -2.56
ImmunityBio, Inc. IBRX Predict 2427.21 -3.63 -4.10
Ikena Oncology, Inc. IKNA Predict 61.29 -1.27 0.52
Inhibikase Therapeutics, Inc. IKT Predict 157.11 -0.95 1.96
Immunocore Holdings plc IMCR Predict 1656.23 None 4.26
Immunovant, Inc. IMVT Predict 2617.36 -14.45 4.30
IN8BIO, INC. INAB Predict 20.73 -0.40 2.41
Inhibrx Biosciences, Inc. INBX Predict 360.87 -6.76 5.26
MiNK Therapeutics, Inc. INKT Predict 59.25 -1.46 -1.36
Inmune Bio, Inc. INMB Predict 67.26 -2.49 2.33
INTENSITY THERAPEUTICS, INC. INTS Predict 7.72 -2.18 3.53
IOVANCE BIOTHERAPEUTICS, INC. IOVA Predict 843.82 -4.50 1.21
Century Therapeutics, Inc. IPSC Predict 48.51 -0.69 0.23
iTeos Therapeutics, Inc. ITOS Predict 392.69 -2.76 0.70
Invivyd, Inc. IVVD Predict 84.94 -0.35 1.99
EXOZYMES INC. IZTC Predict 99.04 None -27.50
Jasper Therapeutics, Inc. JSPR Predict 50.44 -3.21 2.15
Jasper Therapeutics, Inc. JSPRW Predict 3.30 None 0.04
Kalaris Therapeutics, Inc. KLRS Predict 46.01 None 0.87
Klotho Neurosciences, Inc. KLTO Predict 24.52 None 38.39
Klotho Neurosciences, Inc. KLTOW Predict 0.59 None 0.41
Kodiak Sciences Inc. KOD Predict 558.59 -2.45 7.95
Kiromic Biopharma, Inc. KRBPQ Predict 0.01 None None
Krystal Biotech, Inc. KRYS Predict 4480.90 30.54 4.31
Kymera Therapeutics, Inc. KYMR Predict 3423.14 -17.77 3.52
Kyverna Therapeutics, Inc. KYTX Predict 151.79 None 0.82
LadRx Corp LADX Predict None None None
Lineage Cell Therapeutics, Inc. LCTX Predict 266.82 -4.73 5.51
LENZ Therapeutics, Inc. LENZ Predict 1078.73 -6.72 5.23
Liminatus Pharma, Inc. LIMN Predict 0.00 None None
Lexeo Therapeutics, Inc. LXEO Predict 254.87 -0.35 1.84
Maze Therapeutics, Inc. MAZE Predict 590.23 None 2.25
MeiraGTx Holdings plc MGTX Predict 692.75 -3.40 20.93
Metagenomi, Inc. MGX Predict 69.81 None 0.36
Moderna, Inc. MRNA Predict 10899.78 -3.15 1.16
NEUROCRINE BIOSCIENCES INC NBIX Predict 13529.22 38.84 5.02
NKGen Biotech, Inc. NKGN Predict 3.61 -0.10 -0.19
NKGen Biotech, Inc. NKGNW Predict 0.78 None -0.01
Neumora Therapeutics, Inc. NMRA Predict 263.36 -3.90 1.44
NOVAVAX INC NVAX Predict 1699.59 4.02 45.17
Ocugen, Inc. OCGN Predict 297.87 -4.29 18.72
Omega Therapeutics, Inc. OMGA Predict 8.86 -0.68 0.77
Omega Therapeutics, Inc. OMGAQ Predict 0.17 None 0.01
VivoSim Labs, INC. ONVO Predict 34.91 -0.36 95.90
Outlook Therapeutics, Inc. OTLK Predict 73.18 -0.17 -2.25
PALISADE BIO, INC. PALI Predict 3.60 -0.15 0.67
Passage BIO, Inc. PASG Predict 22.09 -0.57 0.58
Vaxcyte, Inc. PCVX Predict 4425.07 -20.36 1.44
BiomX Inc. PHGE Predict 15.21 1.47 0.79
Pluri Inc. PLUR Predict -4.17 -1.36 -9.10
Protalix BioTherapeutics, Inc. PLX Predict 114.92 18.32 2.30
PharmaCyte Biotech, Inc. PMCB Predict 7.32 -2.55 0.18
Prime Medicine, Inc. PRME Predict 480.15 -1.51 7.89
PROKIDNEY CORP. PROK Predict -66.87 None 0.00
Poseida Therapeutics, Inc. PSTX Predict 925.92 -9.59 10.62
Pelthos Therapeutics Inc. PTHS Predict None None None
QIAGEN N.V. QGEN Predict 11089.78 None 3.11
Quince Therapeutics, Inc. QNCX Predict 90.62 -1.66 7.72
Replimune Group, Inc. REPL Predict 931.98 -3.76 2.24
REPLIGEN CORP RGEN Predict 6531.29 8219.12 3.29
REGENXBIO Inc. RGNX Predict 453.55 -1.81 2.12
Relay Therapeutics, Inc. RLAY Predict 607.79 -1.97 0.91
Revolution Medicines, Inc. RVMD Predict 7134.05 -11.09 3.43
Revolution Medicines, Inc. RVMDW Predict 15.98 None 0.01
RECURSION PHARMACEUTICALS, INC. RXRX Predict 2497.43 -4.69 2.72
SAB Biotherapeutics, Inc. SABS Predict 23.99 -2.28 1.12
SAB Biotherapeutics, Inc. SABSW Predict 0.34 None 0.01
Sana Biotechnology, Inc. SANA Predict 792.53 -2.06 6.47
Scilex Holding Co SCLX Predict 61.59 -0.41 -0.29
Scilex Holding Co SCLXW Predict 24.51 None -0.12
Scinai Immunotherapeutics Ltd. SCNI Predict 5325.60 -287.75 -2577.24
SANGAMO THERAPEUTICS, INC SGMO Predict 138.45 -1.56 7.06
Solid Biosciences Inc. SLDB Predict 495.32 -0.85 1.68
Silexion Therapeutics Corp SLXN Predict 4.20 None 34.97
Silexion Therapeutics Corp SLXNW Predict 865.67 None -189.05
Senti Biosciences, Inc. SNTI Predict 50.86 -1.07 1.34
Scholar Rock Holding Corp SRRK Predict 4069.37 -18.48 13.03
Surrozen, Inc./DE SRZN Predict 95.47 -0.49 2.03
Surrozen, Inc./DE SRZNW Predict 0.09 None 0.02
SUTRO BIOPHARMA, INC. STRO Predict 74.55 -1.04 -2.52
SpringWorks Therapeutics, Inc. SWTX Predict 3539.41 -9.90 8.48
Protara Therapeutics, Inc. TARA Predict 125.73 -2.07 0.87
Tarsus Pharmaceuticals, Inc. TARS Predict 2288.26 -12.37 6.88
TC BioPharm (Holdings) plc TCBP Predict 37.26 None 34.48
TC BioPharm (Holdings) plc TCBPW Predict 1.03 None 0.95
TC BioPharm (Holdings) plc TCBPY Predict 17.57 None 16.26
TScan Therapeutics, Inc. TCRX Predict 233.47 -4.63 1.32
BIO-TECHNE Corp TECH Predict 8155.03 75.16 4.04
Tectonic Therapeutic, Inc. TECX Predict 439.92 -8.86 1.55
Instil Bio, Inc. TIL Predict 181.71 -1.13 1.25
Tenaya Therapeutics, Inc. TNYA Predict 158.31 -2.45 1.59
Tourmaline Bio, Inc. TRML Predict 580.57 -3.46 2.24
Turnstone Biologics Corp. TSBX Predict 8.21 -0.14 0.56
Taysha Gene Therapies, Inc. TSHA Predict 834.16 -3.01 3.35
TITAN PHARMACEUTICALS INC TTNP Predict 8.35 -0.46 4.45
Tevogen Bio Holdings Inc. TVGN Predict 183.62 None -29.30
Tevogen Bio Holdings Inc. TVGNW Predict 11.47 None -1.85
Twist Bioscience Corp TWST Predict 1692.09 -12.57 3.54
Voyager Acquisition Corp./Cayman Islands VACH Predict -1435.48 None 0.00
Voyager Acquisition Corp./Cayman Islands VACHU Predict -1584.56 None 0.00
Vericel Corp VCEL Predict 1866.82 262.67 6.08
Vigil Neuroscience, Inc. VIGL Predict 383.88 -1.06 9.30
Vir Biotechnology, Inc. VIR Predict 627.77 -2.04 0.66
VivoSim Labs, INC. VIVS Predict 3.32 None 0.32
Vor Biopharma Inc. VOR Predict 268.88 -0.56 3.91
Vaxart, Inc. VXRT Predict 84.70 -0.85 2.58
Voyager Therapeutics, Inc. VYGR Predict 218.24 570.60 0.90
WINDTREE THERAPEUTICS INC /DE/ WINT Predict 18.34 -0.44 4.16
X4 Pharmaceuticals, Inc XFOR Predict 8.28 6.44 0.36
Zivo Bioscience, Inc. ZIVO Predict 69.66 -31.25 -1.99
Zura Bio Ltd ZURA Predict 130.60 5.01 0.94

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...